HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1349Erstellt: 23. Oktober 2026
Dimethylformamide → 1-(2'-Methoxybiphen-4-ylcarbonyl)-5-oxo-2,3,4,5-tetrahydro-1h-1-benzazepine
https://huagongshe.com/de/reaction/1349
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Dimethylformamide | HCID 6228 | — |
| Edukt | Oxalyl chloride | HCID 65578 | — |
| Edukt | 1,2,3,4-Tetrahydro-benzo(b)azepin-5-one | HCID 294788 | — |
| Edukt | 2-Methoxy-[1,1'-biphenyl]-4-carboxylic acid | HCID 17997392 | — |
| Lösungsmittel | Water | HCID 962 | — |
| Lösungsmittel | Dichloromethane | HCID 6344 | — |
| Lösungsmittel | Triethylamine | HCID 8471 | — |
| Produkt | 1-(2'-Methoxybiphen-4-ylcarbonyl)-5-oxo-2,3,4,5-tetrahydro-1h-1-benzazepine | HCID 54335813 | — |
Reaktionsschritte
A 1.67 g portion of 2-methoxybiphen-4-ylcarboxylic acid was dissolved in 17 ml of dichloromethane, 0.95 ml of oxalyl chloride and a catalytically effective amount of dimethylformamide were added to the resulting solution with cooling on an ice bath and then the resulting mixture was warmed up to room temperature. When completion of foaming was confirmed, the reaction solution was concentrated under a reduced pressure and subjected to azeotropic treatment with toluene twice. The thus obtained residue was dissolved in 8.4 ml of dichloromethane and, with cooling on an ice bath, the resulting solution was dropwise added to a solution obtained by dissolving 1.0 g of 5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine and 1.53 ml of triethylamine in 10 ml of dichloromethane. The reaction solution was warmed up to room temperature and the stirring was continued for 1 hour. The resulting reaction solution was mixed with water and subjected to phase separation to separate dichloromethane layer which was subsequently washed with 0.5N hydrochloric acid and a saturated sodium bicarbonate aqueous solution and dried over anhydrous magnesium sulfate. After removing the solvent by distillation, the thus obtained residue was crystallized from toluene to obtain 1.65 g of 1-(2'-methoxybiphen-4-ylcarbonyl)-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine as crude crystals.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US05723606 |
|---|
| Quelldatensatz | uspto-grants-1998_03 |
|---|
| ORD ID | ord-3679fbd88dec487795772a47ae39b783 |
|---|
| Quellennotiz | uspto-grants-1998_03 |
|---|